Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I1TM
|
||||
Former ID |
DIB012371
|
||||
Drug Name |
FP-1102
|
||||
Synonyms |
Farbetics; FP-1101; AOC3 protein inhibitors (incipient vasculopathies), Faron Pharmaceuticals; Vascular adhesion protein 1 inhibitor (incipient vasculopathies), Faron Pharmaceuticals; Vitamin B1 analog (incipient vasculopathies), Faron Pharmaceuticals
|
||||
Indication | Vascular disease [ICD9: 325, 430-459; ICD10:G45-G46, I60-I95] | Investigative | [543706] | ||
Company |
Faron Pharmaceuticals Ltd
|
||||
Target and Pathway | |||||
Target(s) | Membrane copper amine oxidase | Target Info | Inhibitor | [543706] | |
PANTHER Pathway | Phenylethylamine degradation | ||||
PathWhiz Pathway | Beta-Alanine Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.